探索社区药剂师主导的药物审查研究中的异质性 - 一个系统性审查
Cathrin J Vogt1, Robert Moecker1, Christian O Jacke2
1Heidelberg University, Medical Faculty Heidelberg/Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; Cooperation Unit Clinical Pharmacy, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
由社区药剂师 (CP) 进行的药物评价显示,由于研究设计非标准化,有效性不一致. 标准化患者选择,干预细节和结果措施对于可靠的研究结果至关重要.
科学领域:
- 制药科学 制药科学
- 医疗保健服务研究 医疗服务研究
- 临床药房 临床药房
背景情况:
- 社区药剂师主导的药物审查的有效性通常是不确定的.
- 假设研究设计中缺乏标准化,这阻碍了得出坚定的结论.
研究的目的:
- 在社区药剂师领导的药物审查研究中调查患者选择,干预组件,结果类型和测量仪器的变化.
- 确定在研究方法论中改善标准化的领域.
主要方法:
- 对社区药剂师主导的药物审查的随机对照试验的系统文献搜索.
- 对患者选择,干预和结果的数据的提取和频率分析.
- 将结果映射到核心成果集 (COS) 中,并进行网络分析.
主要成果:
- 分析了30篇文章 (26项研究),揭示了不同的患者选择标准 (特定于药物/疾病,年龄≥60,多种药物).
- 大多数审查都包括了审查本身以外的额外干预措施.
- 结果的广泛范围 (大约. 40) 报告使用各种测量仪器;核心结果集 (COS) 很少使用.
结论:
- 研究设计的显著异质性,包括患者选择,干预交付和结果评估,阻碍了可比性.
- 使用核心成果集 (COS) 和标准化工具进行干预描述和结果评估的标准化对于未来的研究至关重要.
相关概念视频
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...


